Results 101 to 110 of about 1,388,675 (309)
Drug Recognition and Evaluation regions
No relief shown.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.Mode of access: Internet from the Oregon ...
core
Policing alcohol and illicit drug use among Aboriginal and Torres Strait Islander people in metropolitan environments [PDF]
Executive summary: This report presents the results of Australian Institute of Criminology research on issues and challenges of policing alcohol and illicit drug use among Aboriginal and Torres Strait Islander people in metropolitan environments.
David Marks, Jason Payne, Tracy Cussen
core
Protein aggregates threaten proteostasis and cell health. In human cells, Hsp70–J‐domain protein‐based disaggregases remove aggregates, but how they assemble remains unclear. Our biochemical findings show that DNAJA2‐ and DNAJB1‐containing disaggregase scaffolds enhance luciferase aggregate targeting, and that Hsp70 recruitment by both J‐domain ...
Anna Szlachcic, Nadinath B. Nillegoda
wiley +1 more source
The number of quantitative systems pharmacology (QSP) submissions to the U.S. Food and Drug Administration has continued to increase over the past decade. This report summarizes the landscape of QSP submissions as of December 2023. QSP was used to inform
Jane P. F. Bai +10 more
doaj +1 more source
The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce +11 more
wiley +1 more source
Drug Program Evaluation: Outcome Measures
This paper outlines a method of outcome evaluation which allows for a client to be tracked throughout a treatment episode, so that a client's behavioral status can be assessed while remaining in treatment.
Murphy, John W
core +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Modernising Drug Law Enforcement: Applying harm reduction principles to the policing of retail drug markets [PDF]
Key Points: • The level of harm is more important than the size of the market. • Visible, open air drug markets tend to be more harmful per unit of use than hidden, closed drug markets • Policing tactics that are not experienced by the community as ...
Stevens, Alex
core
Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley +1 more source
Elements of effective drug education.
The Drug Education Forum's paper on the learning cycle looks at each element of the cycle covering guidance on needs assessment, planning, delivery/intervention, reflection and assessment and evaluation.
core

